Lehman Gregg Owen 4
4 · InfuSystem Holdings, Inc · Filed Sep 12, 2022
Insider Transaction Report
Form 4
Lehman Gregg Owen
Director
Transactions
- Exercise/Conversion
Common Stock
2022-09-08$3.18/sh+8,889$28,267→ 9,235 total - Sale
Common Stock
2022-09-08$7.75/sh−8,889$68,853→ 346 total - Exercise/Conversion
Stock Option (right to buy)
2022-09-09−4,468→ 21,643 totalExercise: $3.18Exp: 2023-08-23→ Common Stock (4,468 underlying) - Exercise/Conversion
Common Stock
2022-09-09$3.18/sh+4,468$14,208→ 4,814 total - Sale
Common Stock
2022-09-12$7.88/sh−1,900$14,972→ 346 total - Sale
Common Stock
2022-09-09$7.83/sh−4,468$34,992→ 346 total - Exercise/Conversion
Common Stock
2022-09-12$3.18/sh+1,900$6,042→ 2,246 total - Exercise/Conversion
Stock Option (right to buy)
2022-09-08−8,889→ 26,111 totalExercise: $3.18Exp: 2023-08-23→ Common Stock (8,889 underlying) - Exercise/Conversion
Stock Option (right to buy)
2022-09-12−1,900→ 19,743 totalExercise: $3.18Exp: 2023-08-23→ Common Stock (1,900 underlying)
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares reported herein were sold in multiple transactions. The reporting person undertakes to provide to the Issuer, and security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
- [F2]The option, representing the right to purchase 35,000 shares of InfuSystem Holdings, Inc. common stock, vests in twelve monthly installments beginning September 23, 2018.